The project’s purpose is to support the implementation of the declaration of cooperation ‘Towards access to at least 1 million sequenced genomes in the EU by 2022‘, known as the 1+ Million Genomes initiative (1+MG). Today, 22 signatory countries work together to ensure that the objectives are met by 2022, to ultimately improve disease prevention, personalised treatment and clinical research.
Until now, Member States have been working to initiate these efforts through ad-hoc working groups, but without the benefit of a formal coordination project to offer structure and international collaboration. The B1MG project provides the required coordination, support and expertise to move ‘beyond’ the 1M genome target and ‘beyond’ the 21 signatory countries of the original initiative.
ELIXIR is partly funded by the European Commission